Hemrick-Luecke SK[au] - Search Results

Year	Number of Results
1980	2
1981	8
1982	4
1983	8
1984	1
1985	7
1986	5
1987	4
1988	6
1989	4
1990	2
1992	4
1993	1
1994	3
1995	4
1996	3
1998	1
2000	1
2001	1
2002	3
2003	1
2004	1
2005	2
2006	1
2007	1
2008	1
2013	1
2023	0

1

Discovery of a potent, dual serotonin and norepinephrine reuptake inhibitor.

Dreyfus N, Myers JK, Badescu VO, de Frutos O, de la Puente ML, Ding C, Filla SA, Fynboe K, Gernert DL, Heinz BA, Hemrick-Luecke SK, Johnson KW, Johnson MP, López P, Love PL, Martin LJ, Masquelin T, McCoy MJ, Mendiola J, Morrow D, Muhlhauser M, Pascual G, Perun TJ, Pfeifer LA, Phebus LA, Richards SJ, Rincón JA, Seest EP, Shah J, Shaojuan J, Simmons RM, Stephenson GA, Tromiczak EG, Thompson LK, Walter MW, Weber WW, Zarrinmayeh H, Thomas CE, Joshi E, Iyengar S, Johansson AM. Dreyfus N, et al. Among authors: hemrick luecke sk. ACS Med Chem Lett. 2013 May 7;4(6):560-4. doi: 10.1021/ml400049p. eCollection 2013 Jun 13. ACS Med Chem Lett. 2013. PMID: 24900709 Free PMC article.

2

Monoaminergic compensation in the neuropeptide Y deficient mouse brain.

Gehlert DR, Thompson LK, Hemrick-Luecke SK, Shaw J. Gehlert DR, et al. Among authors: hemrick luecke sk. Neuropeptides. 2008 Jun;42(3):367-75. doi: 10.1016/j.npep.2007.10.005. Epub 2008 Mar 7. Neuropeptides. 2008. PMID: 18329096

3

Evaluation of nefazodone as a serotonin uptake inhibitor and a serotonin antagonist in vivo.

Hemrick-Luecke SK, Snoddy HD, Fuller RW. Hemrick-Luecke SK, et al. Life Sci. 1994;55(7):479-83. doi: 10.1016/0024-3205(94)00739-x. Life Sci. 1994. PMID: 8041227

4

Depletion of cardiac norepinephrine but not brain catecholamines by MPTP-N-oxide in mice.

Hemrick-Luecke SK, Robertson DW, Fuller RW. Hemrick-Luecke SK, et al. Life Sci. 1990;47(9):815-9. doi: 10.1016/0024-3205(90)90554-5. Life Sci. 1990. PMID: 2215082

5

Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.

Fuller RW, Hemrick-Luecke SK, Perry KW. Fuller RW, et al. Among authors: hemrick luecke sk. J Pharmacol Exp Ther. 1988 Nov;247(2):531-5. J Pharmacol Exp Ther. 1988. PMID: 3141609

6

5'-thioadenosine derivatives as potent and selective inhibitors of histamine N-methyltransferase.

Crooks PA, Hassan SF, Benghiat E, Hemrick-Luecke SK, Fuller RW. Crooks PA, et al. Among authors: hemrick luecke sk. Drug Metabol Drug Interact. 1989;7(2-3):111-41. doi: 10.1515/dmdi.1989.7.2-3.111. Drug Metabol Drug Interact. 1989. PMID: 2630176

7

Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor.

Fuller RW, Hemrick-Luecke SK, Snoddy HD. Fuller RW, et al. Among authors: hemrick luecke sk. J Neural Transm Gen Sect. 1994;96(3):165-77. doi: 10.1007/BF01294784. J Neural Transm Gen Sect. 1994. PMID: 7826568

8

Potent in vivo but not in vitro inhibition of monoamine oxidase by 3-chloro-alpha-phenylpyrazinemethanol.

Fuller RW, Hemrick-Luecke SK, Ward JS. Fuller RW, et al. Among authors: hemrick luecke sk. Neurochem Int. 1992 Jan;20(1):37-42. doi: 10.1016/0197-0186(92)90123-9. Neurochem Int. 1992. PMID: 1304317

9

A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity.

Fuller RW, Hemrick-Luecke SK. Fuller RW, et al. Among authors: hemrick luecke sk. J Pharm Pharmacol. 1989 Jul;41(7):492-3. doi: 10.1111/j.2042-7158.1989.tb06509.x. J Pharm Pharmacol. 1989. PMID: 2570859

10

MK801 antagonism of the prolonged depletion of striatal dopamine by amphetamine in iprindole-treated rats.

Hemrick-Luecke SK, Henderson MG, Fuller RW. Hemrick-Luecke SK, et al. Life Sci. 1992;50(6):PL31-3. doi: 10.1016/0024-3205(92)90383-z. Life Sci. 1992. PMID: 1734157

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results